Journal List > J Korean Ophthalmol Soc > v.55(11) > 1009836

Kim, Rho, and Kim: Late-Onset Endophthalmitis Associated with Glaucoma Surgery

Abstract

Purpose

To report cases of late-onset endophthalmitis associated with glaucoma surgery.

Methods

We retrospectively reviewed the medical records of 4905 consecutive patients who underwent glaucoma surgery (trabeculectomy or valve implant surgery) from January 1, 1988 to March 31, 2013.

Results

There were a total of 14 late-onset endophthalmitis (0.29%) cases associated with glaucoma surgery occurring at 1 year to 21 years postoperatively. Six cases (6/993, 0.60%) occurred after valve implantation and the other 8 cases (8/3912, 0.20%) occurred after trabeculectomy (p = 0.046). All but one patient were injected with fortified vancomycin and ceftazidim. Four patients also received a vitrectomy with the injection. The implanted valve was removed in 2 cases. In four cases, organisms were found in the culture (staphylococcus.aureus, streptococcus viridians, propionibacterium acnes and candida parapsilosis). After 1 year, only 4 patients achieved a visual acuity above 4/200 compared with other patients who had a final visual acuity of hand motion or worse. Three patients (33%) who developed endophthalmitis underwent other intraocular procedures.

Conclusions

Late-onset endophthalmitis associated with glaucoma surgery can often occur with fulminant sight-threatening complications. Due to devastating sequelae, the surgeon should carefully check the surgery site in the patients who underwent glaucoma surgery at every follow-up visit. Delayed endophthalmitis after glaucoma surgery still carries a poor visual prognosis and its onset is difficult to predict. Therefore, patients who undergo glaucoma surgery should be educated and carefully evaluated during regular follow-ups.

References

1. Aaberg TM Jr, Flynn HW Jr, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology. 1998; 105:1004–10.
2. Eifrig CW, Flynn HW Jr, Scott IU, Newton J. Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers. 2002; 33:373–8.
crossref
3. Kattan HM, Flynn HW Jr, Pflugfelder SC, et al. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology. 1991; 98:227–38.
4. Wu PC, Kuo HK, Li M, et al. Nosocomial postoperative endophthalmitis: a 14-year review. Graefes Arch Clin Exp Ophthalmol. 2006; 244:920–9.
crossref
5. Price FW Jr, Wellemeyer M. Long-term results of Molteno implants. Ophthalmic Surg. 1995; 26:130–5.
crossref
6. Nguyen QH, Budenz DL, Parrish RK 2nd. Complications of Baerveldt glaucoma drainage implants. Arch Ophthalmol. 1998; 116:571–5.
crossref
7. Djodeyre MR, Peralta Calvo J, Abelairas Gomez J. Clinical evaluation and risk factors of time to failure of Ahmed Glaucoma Valve implant in pediatric patients. Ophthalmology. 2001; 108:614–20.
8. Morad Y, Donaldson CE, Kim YM, et al. The Ahmed drainage implant in the treatment of pediatric glaucoma. Am J Ophthalmol. 2003; 135:821–9.
crossref
9. Johnson MW, Doft BH, Kelsey SF, et al. The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology. 1997; 104:261–72.
10. Busbee BG, Recchia FM, Kaiser R, et al. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology. 2004; 111:1495–503. discussion 1503.
11. Higginbotham EJ, Stevens RK, Musch DC, et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology. 1996; 103:650–6.
crossref
12. Greenfield DS, Suñer IJ, Miller MP, et al. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol. 1996; 114:943–9.
crossref
13. Uhm KB, Kim TW, Kim JH, Hong C. Risk Factors for the Development of Thin-walled Blebs after Mitomycin C Trabeculectomy. J Korean Ophthalmol Soc. 1996; 37:1032–44.
14. Parrish R, Minckler D. “Late endophthalmitis”. –filtering surgery time bomb? Ophthalmology. 1996; 103:1167–8.
15. Mandelbaum S, Forster RK. Endophthalmitis associated with filtering blebs. Int Ophthalmol Clin. 1987; 27:107–11.
crossref
16. Al-Torbak AA, Al-Shahwan S, Al-Jadaan I, et al. Endophthalmitis associated with the Ahmed glaucoma valve implant. Br J Ophthalmol. 2005; 89:454–8.
crossref
17. Francis BA, DiLoreto DA Jr, Chong LP, Rao N. Late-onset bacteria endophthalmitis following glaucoma drainage implantation. Ophthalmic Surg Lasers Imaging. 2003; 34:128–30.
18. Kil YG, Jin SM, Chung DY. A case of late onset bleb-related endophthalmitis after trabeculectomy with mitomycin C. J Korean Ophthalmol Soc. 1999; 40:2036–42.
19. Cha SC, Lee KW, Hahn DK. Late onset endophthalmitis following filtering surgery. J Korean Ophthalmol Soc. 1988; 29:195–9.
20. Kim JH, Sohn YH, Uhm KB, Hong C. Two cases of bleb-related endophthalmitis after trabeculectomy with mitomycin C. J Korean Ophthalmol Soc. 1997; 38:336–42.
21. Jampel HD, Quigley HA, Kerrigan-Baumrind LA, et al. Risk factors for late-onset infection following glaucoma filtration surgery. Arch Ophthalmol. 2001; 119:1001–8.
crossref
22. Mochizuki K, Jikihara S, Ando Y, et al. Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment. Br J Ophthalmol. 1997; 81:877–83.
crossref
23. Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002; 109:985–91.
24. Fanous MM, Cohn RA. Propionibacterium endophthalmitis following Molteno tube repositioning. J Glaucoma. 1997; 6:201–2.
crossref
25. Chen PP, Palmberg PF. Needling revision of glaucoma drainage device filtering blebs. Ophthalmology. 1997; 104:1004–10.
crossref
26. Beck AD, Wilson WR, Lynch MG, et al. Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. Am J Ophthalmol. 1998; 126:648–57.
crossref
27. Sidoti PA, Belmonte SJ, Liebmann JM, Ritch R. Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. Ophthalmology. 2000; 107:422–9.
28. Gedde SJ, Scott IU, Tabandeh H, et al. Late endophthalmitis associated with glaucoma drainage implants. Ophthalmology. 2001; 108:1323–7.
crossref
29. Perkins TW. Endophthalmitis after placement of a Molteno implant. Ophthalmic Surg. 1990; 21:733–4.
crossref
30. Ellis BD, Varley GA, Kalenak JW, et al. Bacterial endophthalmitis following cataract surgery in an eye with a preexisting Molteno implant. Ophthalmic Surg. 1993; 24:117–8.
crossref
31. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002; 133:463–6.
32. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol. 1995; 113:1479–96.
33. Tsai JC, Johnson CC, Kammer JA, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma II: longer-term outcomes from a single surgeon. Ophthalmology. 2006; 113:913–7.
34. Woodcock MG, Richards JC, Murray AD. The last 11 years of Molteno implantation at the University of Cape Town. Refining our indications and surgical technique. Eye (Lond). 2008; 22:18–25.
crossref
35. Lehmann OJ, Bunce C, Matheson MM, et al. Risk factors for development of post-trabeculectomy endophthalmitis. Br J Ophthalmol. 2000; 84:1349–53.
crossref

Figure 1.
Representative image of slit lamp photograph shows conjunctival injection and hypopyon (case 8).
jkos-55-1651f1.tif
Figure 2.
Representative image of B-scan ultrasonograph shows posterior vitreous opacification and multiple abnormal vitreous spikes (case 8).
jkos-55-1651f2.tif
Figure 3.
Representative images of slit lamp photograph shows markedly injected conjunctiva and thin, cystic bleb (case 4).
jkos-55-1651f3.tif
Table 1.
Incidences of endopthalmitis associated with glaucoma surgery
Type of surgery Total cases (n) Infected cases (n)
Trabeculectomy 3,912 8 (0.20%)
Valve implant surgery 993 6 (0.60%)
Total 4,905 14 (0.29%)
p-value 0.046

p-value by Fisher's exact test: means statistically significant difference (p<0.05).

Table 2.
Baseline demographic and clinical features for the 4,905 patients with glaucoma filtering surgery
Characteristics Values
Age (years)
 Mean ± SD 55.15 ± 17.24
Sex (n, %)
 Female 2,188 (44.61)
 Male 2,717 (55.39)
Systemic diseases (n, %)
 Diabetes mellitus 815 (16.62)
Glaucoma type (n, %)
 Primary open-angle glaucoma 2,147 (43.77)
 Primary angle closure glaucoma 669 (13.64)
 Normal tension glaucoma 18 (0.37)
 Secondary glaucoma 1,447 (29.50)
 Neovascular glaucoma 564 (11.50)
 Primary congenital glaucoma 60 (1.22)
Glaucoma surgery type (n, %)
 Trabeculectomy 3,912 (80.00)
 Tube implantation 993 (20.00)
Presence of other ocular surgery (n, %) 2,798 (57.00)
Antimetabolite (MMC) used (n, %) 1,917 (49.00)

Values are presented as mean ± SD unless otherwise indicated. MMC = mitomycin-C.

Table 3.
Summary of patients
Case no. Sex/Age (years) Associated systemic disease Glaucoma diagnosis Symptom duration Presenting visual acuity Interval Type of surgery Mitomycin-C use Status of glaucoma surgery site Treatment Culture organism Other operation (time) Final visual acuity
1 M/68 HBP 2nd glaucoma 1 day 8/200 16 years Trabeculectomy Yes Nearly melted conjunctiva, leak (+) Intravitreal vancomycin + ceftazidim injection No growth 20/200
2 M/49 none CACG 2 days LP(+) 21 years Trabeculectomy Yes Pus tinged bleb Intravitreal, intracameral and subconjunctival vancomycin + ceftazidim injection No growth HM
3 M/33 none POAG the day CF 9 years Trabeculectomy Yes Bleb thinning, leak (+) Intravitreal and subconjunctival vancomycin + ceftazidim injection No growth 4/200
4 M/49 none POAG 1 day HM 2 years and 6 months Trabeculectomy Yes Pus tinged bleb Intravitreal vancomycin + ceftazidim injection, ppV Staphyococcus. aureus LP(-)
5 M/50 none POAG 1 day HM 19 years Trabeculectomy No Pus tinged bleb Intravitreal vancomycin + ceftazidim injection, ppV No growth Phacoemulsification + PCL in sertion (14 years after trabeculectomy) LP(-)
6 M/56 none 2nd glaucoma 2 days 12/200 13 months Ahmed valve implantation + scleral graft No Thin conjunctiva on valve Intravitreal vancomycin + ceftazidim injection No growth PKP (twice, 3 months prior to ahmed valve implantation) LP(-)
7 M/59 none 2nd glaucoma the day LP(+) 8 years and 6 months Ahmed valve implantation No Conjunctival inflammation with exposed valve Intravitreal vancomycin + ceftazidim injection No growth l’ closure, ppV (1 year prior to ahmed valve implantation), PKP (3 years after ahmed valve implanatation) LP(+)
8 M/80 DM POAG 1 year LP(-) 1 year Ahmed valve implantation NR Bullae on conjunctiva Ahmed valve removal, evisceration No growth LP(-)
9 M/68 none Advanced glaucoma (NVG + AACG) 1 day HM 5 years Molteno tube implantation No Well positioned valve Intravitreal vancomycin + ceftazidim injection No growth ppV (6 months after Molteno tube implantation) HM
10 M/56 none Uveitic glaucoma 2 days HM 8 months Trabeculectomy Yes Pus tinged bleb Intravitreal vancomycin + ceftazidim injection, ppV Streptococcus viridans Phacoemulsification + PCL in sertion (8 years prior to trabeculectomy) LP(-)
11 M/34 none Secondary glaucoma 2 days HM 1 year Ahmed valve implantation + ppv NR Well positioned valve Intravitreal vancomycin + ceftazidim injection, ppV Propionibacterium acnes Ciliary body retension cyst removal (1 year 4 months prior to valve surgery) LP(-)
12 M/64 none POAG 10 days 0.16 12 years Ahmed valve implantation NR Ahmed valve tip exposure Intravitreal vancomycin + ceftazidim injection, ahmed valve removal No growth Trabeculectomy (7 years prior to ahmed valve implantation) phacoemulsification + PCL in sertion (8 years prior to ahmed valve implantation 50/200
13 F/69 DM POAG 30 days LP(-) 7 years Trabeculectomy + pressure regulator insertion No Exposed tube with whitish pus Tube removal & AC irrigation & intracameral vancomycin + ceftazidim injection Candida parapsilosis Trabeculectomy (6 years prior to 2nd trabeculectomy) LP(-)
14 F/36 none POAG 2 days CF 13 years Trabeculectomy Yes Bleb thinning, leak(+) Topical fortified antibiotics No growth Trabeculectomy (2 years prior to 2nd trabeculectomy) 40/200

HBP = high blood pressure; CACG = chronic angle closure glaucoma; POAG = primary open angle glaucoma; PCL = posterior chamber lens; AACG = acute angle closure glaucoma; NVG = neovascular glaucoma; DM = diabetes mellitus; LP (+) = light perception; CF = counting fingers; HM = handmotion; LP (-) = no light perception; ppV = pars plana vitrectomy; NR = notrecorded; PKP = penetrating keratoplasty.

Duration of symptom before diagnosis of endophthalmitis;

Interval between glaucoma surgery and diagnosis of endophthalmitis;

Final visual acuity 6 months after diagnosis.

TOOLS
Similar articles